Deregulation to revitalize OTC market

Published: 2009-01-15 07:00:00

Updated: 2009-01-15 07:00:00

OTC drugmakers is breathing a sigh of relief as the Korea Food and Drug Administration is actively moving ahead to deregulate validation rules governing OTC products with standardized dosage and formulation method.

According to the KFDA, the mandatory submission of validation documents for new...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK